| HVZV95 vs Jin | 83–104 | 44.39% |
| HVZV95 vs Kazuya | 77–81–2 | 48.73% |
| HVZV95 vs Bryan | 74–71 | 51.03% |
| HVZV95 vs King | 52–67 | 43.70% |
| HVZV95 vs Steve | 49–64 | 43.36% |
| HVZV95 vs Dragunov | 37–62 | 37.37% |
| HVZV95 vs Reina | 56–38 | 59.57% |
| HVZV95 vs Yoshimitsu | 40–52 | 43.48% |
| HVZV95 vs Lidia | 35–49 | 41.67% |
| HVZV95 vs Hwoarang | 43–34 | 55.84% |
| HVZV95 vs Law | 34–39 | 46.58% |
| HVZV95 vs Azucena | 30–30 | 50.00% |
| HVZV95 vs Lili | 25–28 | 47.17% |
| HVZV95 vs Jun | 16–37 | 30.19% |
| HVZV95 vs Devil Jin | 18–34 | 34.62% |
| HVZV95 vs Paul | 24–25 | 48.98% |
| HVZV95 vs Lee | 25–19 | 56.82% |
| HVZV95 vs Feng | 20–22 | 47.62% |
| HVZV95 vs Victor | 15–25 | 37.50% |
| HVZV95 vs Asuka | 14–22 | 38.89% |
| HVZV95 vs Lars | 14–22 | 38.89% |
| HVZV95 vs Eddy | 15–20 | 42.86% |
| HVZV95 vs Clive | 14–19 | 42.42% |
| HVZV95 vs Xiaoyu | 13–19 | 40.62% |
| HVZV95 vs Nina | 15–17 | 46.88% |
| HVZV95 vs Jack-8 | 11–18 | 37.93% |
| HVZV95 vs Leroy | 8–16 | 33.33% |
| HVZV95 vs Claudio | 6–16 | 27.27% |
| HVZV95 vs Shaheen | 10–12 | 45.45% |
| HVZV95 vs Heihachi | 6–15 | 28.57% |
| HVZV95 vs Raven | 9–10 | 47.37% |
| HVZV95 vs Leo | 10–6 | 62.50% |
| HVZV95 vs Alisa | 7–9 | 43.75% |
| HVZV95 vs Kuma | 5–4 | 55.56% |
| HVZV95 vs Panda | 4–5 | 44.44% |
| HVZV95 vs Zafina | 4–5 | 44.44% |
| HVZV95 vs Armor King | 4–4 | 50.00% |
Limitations
This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.
For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.
There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.
In the meantime, this page is here to present the data as requested.